Effect of Omeprazole on the Pharmacokinetics of SHR6390 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 27, 2021

Primary Completion Date

January 26, 2022

Study Completion Date

February 14, 2022

Conditions

Advanced Solid Tumor

Interventions

DRUG

SHR6390、Omeprazole

SHR6390 tablet single dose、Omeprazol single dose.

Trial Locations (1)

Shanghai Xuhui Central Hospital, Shanghai

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04989829 - Effect of Omeprazole on the Pharmacokinetics of SHR6390 in Healthy Subjects | Biotech Hunter | Biotech Hunter